A quick google tells me that (a) this is for lung cancer and (b) doesn't appear to be a radiation therapy.
Telix is addressing lung cancer- along with many other cancers- as part of its STARBURST trial but it's not a specific target of a major program right now was far as I am aware.
The company that might be pleased at someone else's failure is RAD, who have a Phase 1 trial for lung cancer happening in Adelaide. I only know a tiny bit about RAD so cannot say anything useful about that company.
General comments about how the trial failure affects the landscape etc etc no idea sorry.
However, the reason I was looking up Adelaide clinical trial data was because I was trying to find out more about Telix's APOMAB collaboration/ trial, which I haven't heard anything about recently. A general question for everyone: Have I missed something?
Understanding Telix, page-1445
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.22 |
Change
0.060(0.28%) |
Mkt cap ! $7.101B | |||
| Open | High | Low | Value | Volume |
| $21.14 | $21.40 | $20.75 | $16.20M | 767.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | $21.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.25 | 457 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |